Samsung Biologics Approves Acquisition of 426 Billion KRW Site for Songdo 2nd Bio Campus
[Asia Economy Reporter Yoo Byung-don] Samsung Biologics announced on the 29th that its board of directors has approved the acquisition of the Ki19 site in the Advanced Industrial Cluster (C) of Songdo International City from the Incheon Free Economic Zone Authority (IFEZ).
The acquisition price is approximately 426 billion KRW, accounting for 5.35% of the total assets.
This site is planned to be used as the location for the 2nd Bio Campus.
Hot Picks Today
Samsung Electronics Union Reaches Tentative Agreement on Bonus Negotiations... "General Strike Postponed"
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Was It You Again?" Elementary Student Involved in Last Week's Vehicle Theft Drives Off Himself This Time
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The scheduled acquisition date is April 30.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![[Breaking] Samsung Electronics Labor and Management Officially Sign Tentative Agreement](https://cwcontent.asiae.co.kr/asiaresize/307/2026052022492353201A.jpg)
